MRNS Price Targets and Analyst Ratings NASDAQ:MRNS
MRNS Forecast. What You Should Know.
MRNS Historical Ratings and Targets
About Marinus Pharmaceuticals
Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The... MRNS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.